Nilesh Kumar, Ph.D.

Nilesh is a partner at Novo Ventures and serves on the boards of Tarveda, Rgenix and Cirius. Prior to Novo, Nilesh was senior director at MS Ventures where he invested in several companies including Padlock, Auxogyn, f-Star and RaNA Therapeutics. Nilesh received his PhD and MBA from Harvard University, and did his undergraduate degree in Natural Sciences  at University of Cambridge, UK.